Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for June 2012
June 1, 2012
- Groups Call for Halt to Marketing of Opioids for Long-Term Pain
- Forest Laboratories and Nabriva Therapeutics Sign Agreement
- Cytochroma Regains Rights to Lunacalcipol
- Marina Biotech Ceases Most Day-to-Day Operations
June 4, 2012
- New Drug Helps Immune System Fight Cancer, Study Says
- Astellas Pharma to Open $150 Million North American Headquarters in Northbrook
- WebMD Snares Former Pfizer Exec As CEO
- Astellas and Drais Partner to Develop Second Astellas Compound Through Seldar
- More Advanced Therapies Are Being Aimed at Cancer
- Yale: 'Magic' Antidepressant May Hold Promise For PTSD
- KBA-Sponsored Study Finds Global Contract Research Industry Larger Than Previously Estimated
- Takeda Completes Acquisition of URL Pharma, Inc.
June 5, 2012
- BioInvent and ThromboGenics Announce Results from Phase IIb Venous Thromboembolism Prevention Study with TB-402
- PharmaGap Updates Lead Drug Status and Potential Sale
- Pharmacyclics Rises on Blood Cancer Drug Data
- Pay Consultants Accused of Conflicts of Interest: Advisers Provided Other Services
June 6, 2012
June 7, 2012
- American Medical Systems and Allergan Sign Agreement for JetTouch /Botox Co-Development Program
- First sales of Dificlir by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
- In China, 1 in 10 TB Cases Are Drug-Resistant
- Achillion Says Chief Medical Officer Is Resigning
- 180 Jobs in Danger at Drugs Giant
- Nektar Says Pain Drug Gets Fast Track FDA Status
- 2012 Likely to Be Fourth Consecutive Year of Historically Low Growth in Health Spending
June 8, 2012
- Chelsea Therapeutics Announces $6 Million in Cost Saving Initiatives to Support Expanded Enrollment Initiatives for Northera Study and Extend Cash Runway Into Third Quarter 2013
- Pfizer Test Group Is Moving to Singapore
- Mylan Settles Provigil Litigation With Teva
- Transfer of TAK-070, a Candidate Molecule for the Treatment of Alzheimer-type Dementia, to the National University Corporation
- Human Genome Sciences Responds to GSK Extension of Unsolicited Tender Offer
- Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
June 11, 2012
- Diabetes in the Elderly Remains Little Studied
- GlaxoSmithKline Renews Bid for Human Genome Sciences Shares
- Astellas Pharma: Dificlir, A Novel Treatment for Clostridium Difficile Infections (CDI), Launched in Europe
- Forest Laboratories, Inc. Revises Fiscal Year 2013 Earnings Guidance Primarily Due to Evolving Conditions in the Lexapro / escitalopram Market
- Shire's Advanced BioHealing Commits to Developing Regenerative Medicine Campus in San Diego
- Despite Recession, Global Biosimilars Market Grew Over 40% 2010-2011, Set to Reach $3.6 Billion by 2016
- LILLY (ELI) & COMPANY - 90-week data suggest sustained glucose reduction and weight loss with investigational SGLT-2 inhibitor, empagliflozin
June 12, 2012
- Pharming Undertakes Review Of Strategic Options
- Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
- Genzyme Submits Applications to FDA and EMA for Approval of Lemtrada (alemtuzumab) for Multiple Sclerosis
- Amgen Appeal in Lawsuit to Go to U.S. Supreme Court
- Biogen Idec to Highlight Innovative Pipeline and Commercial Strategy
- Drug Oversight Gets Unanimous NY State OK
- This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
- Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
- Stiefel Signs Worldwide Acquisition and License Agreement for Toctino
- Thiazolidinedione Treatment in Patients with Type 2 Diabetes Appears to be Associated with Increased Risk for Diabetic Macular Edema
- GE's Board Has Elected Marijn E. Dekkers, Chairman, Bayer, AG
- Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
June 13, 2012
- Five More Pharmaceutical Companies Join NIH Initiative to Speed Therapeutic Discovery
- Bayer May Move Corporate Operations to N.J.
- Doctors Raise Questions Over Drug Trials in Developing Countries
- Biggest Mass. Insurer Tightens Rules On Some Painkillers
- Upsher-Smith Announces Transaction to Acquire UK-Based Proximagen
- UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
- Omnicare CEO Resigns After 18 Months
- Patent Expirations Put More Than $290 Billion in Prescription Drug Sales at Risk Through 2018
June 14, 2012
- Nuvo Research Provides Pennsaid Commercial Update
- Lundbeck Plans to Establish A More Flexible Commercial Organisation in Europe
- Drug Industry Gauges Economic Impact of R&D in State
- Dendreon Shareholders Complain About Stock Losses
- PDL Biopharma Says It Expects $125M in 2Q Revenue
- Medicare Drug Discounts At Risk If Court Strikes Health Law
- Shionogi Announces Initial Data From Phase Iib Study of S-555739, Prostaglandin D2 Receptor Antagonist
- Are Billion-Dollar Settlements 'the Cost of Doing Business' in Pharma?
- Johnson & Johnson Announces Completion of Synthes Acquisition
June 15, 2012
- Human Genome Sciences Announces July 16 as the Date for Submission of Definitive Acquisition Proposals
- Bionomics to Expand Kv1.3 Program
- Man Charged in $80M Drug Heist Pleads Not Guilty
- Tris Pharma to Hold Job Fairs - Saturday June 16 and Saturday June 23
- Janssen Submits Additional Marketing Applications for Zytiga in the U.S. and European Union
June 18, 2012
- Have Americans Reached a New Era of Optimism about Aging?
- Updated FDA Statement on Compounded Versions of hydroxyprogesterone caproate (the active ingredient in Makena)
- FDA and CMS Issue Important Updates on Makena
- Mounting the Attack on Lou Gehrig's Disease
- Quintiles Deepens Investment in China
- Amgen Cuts 'Small Number' of Staffers
- Pfizer, Partners Start Website on Addressing Aging
- Merck: Court Rejected Its Claim Over Allergy Drug
- Piramal in Talks to Buy US Contract Drug Maker Cambridge for $200 M [
- FDA: Advocate Health Care Conducted Drug Study Without Patients' Consent
- Sanofi Recalls TB Vaccine Over Quality Issues; Canada Scrambles for New Supply
- Takeda?s Exclusive Distribution of Pfizer Products in Japan
- Ambrx Collaborates with Merck to Design and Develop Biologic Drug Conjugates
- Geisinger and Merck to Collaborate on Multi-year Effort to Improve Patient Adherence, Engagement and Care Delivery
- Merck in Potential $300M Research Deal With Ambrx
- AC Immune and Genentech Enter into Second Antibody Collaboration for Alzheimer?s Disease
- Drug Sales People Don't Get Overtime
June 19, 2012
- New Survey Finds Most Canadians Underestimate the Risk of Getting Shingles - Shingles Vaccine Now Readily Available
- Merck Serono Announces Final Efficiency Program for Switzerland
- Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
June 20, 2012
- Massachusetts, Israel Announce Research Funding Collaborations
- Walgreens, Allied Boots Strike Deal
- Icahn Names 4 Nominees to Forest Labs Board
- CSL Biotherapies Provides Update on Fluvax Investigation
- Bristol-Myers Squibb and Emory University Announce Partnership to Advance Clinical Development of Investigational Compounds
- Alexion Moving To New Haven, Adding Up To 300 Jobs
- Americans and Biotechnology Executives Remain Optimistic About Future of Biotechnology Despite Serious Industry Concerns Over Increased Regulatory Burdens and Weak Economic Conditions
- Daiichi Sankyo and Ranbaxy Launch Hybrid Business in Venezuela
- Teva Launches Generic Symbyax
June 21, 2012
- Merck Statement on CDC Advisory Committee on Immunization Practices' Recommendation for Pneumococcal Vaccination in Immunocompromised Adults
- Meeting to Brainstorm Future Uses of Pfizer Labs
- US House Sends Drug Bill to Senate for Final Vote
- POZEN Announces FDA Response to Its Phase 1, PA32540 Bioequivalence Study Analyses
- XTL Bio Buys Kitov Pharmaceuticals for Up to $48m
- Oncolytics Says Cancer Drug Study Will Continue
- Idenix Shares Jump After Release of Study Results
June 25, 2012
- Valeant Pharma Rebounds From Thursday Decline
- Teva Soars on Copaxone Patents Victory
- A Tough Environment for Biotech Investing
- Letter from EFPIA President, Sir Andrew Witty, to European Heads of States and Governments
- Double Helix Joins McCann Health
- Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
- Mylan Comments on Copaxone Ruling
June 26, 2012
- Astellas Pharma Launches Kiklin Capsules, a Treatment for Hyperphosphatemia, in Japan
- Dainippon Sumitomo Pharma announces the launch of Sleep Inducing Treatment "Zolpidem tartrate tablets 5mg/10mg [DSP]"
- VELCADE Receives Positive Regulatory Recommendation in the European Union for Subcutaneous Administration
- Watson Confirms Pristiq Patent Challenge
- Vodafone and Exco InTouch partner to develop a Patient Reported Outcomes solution that will transform patient engagement in clinical trials
- Roche to Streamline Research and Development Activities
June 27, 2012
- FDA Drug Safety Communication: Cefepime and Risk of Seizure in Patients not Receiving Dosage Adjustments for Kidney Impairment
- Merck and AstraZeneca Agree to Amend Partnership
- Senate Passes Pdufa V; Next Stop: President's Signature
- Merck Serono Announces First Employment Initiative for Employees Affected By Restructuring in Switzerland
- A Drug to Cure Double Chins?
- AMAG Pharmaceuticals Realigns Operating Cost Structure to Focus on Continued Feraheme Growth and Business Development Activities
- Pozen Issued Patent Covering Aspirin Candidates
June 28, 2012
- FDA Seeks To Tame Exploding Medical App Market
- Janssen Acquires CorImmun
- Amarin Stock Soars on Hints of Patent OK
- In Approving New Diet Drug, FDA Ignores Crucial Safety Data
- AstraZeneca in Demand As Long Term Seller Turns Positive at Glaxo's Expense
- Supreme Court Upholds 2010 Health Care Overhaul Law
June 29, 2012
- Supreme Court Decision to Uphold Healthcare Law Means "Game On" for Health Industry: Crunch Time for Those Who Waited, Says PwC
- Anthera Pharma Plunges on Lupus Drug Study Results
- Vertex Skids on Cystic Fibrosis Trial Data
- GlaxoSmithKline Dips on Renewed Talk of Interest in US Group Biomarin
- MedicationMarketing: How the Pharma Industry is Using Social Media to Sell
- Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
- Human Genome Sciences Responds To GSK Extension of Unsolicited Tender Offer
- Forest Laboratories Issues Statement on Icahn Letter
- Monthly News Round Up - June 2012
